These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10419460)

  • 1. Tissue plasminogen activator binds to human vascular smooth muscle cells by a novel mechanism. Evidence for a reciprocal linkage between inhibition of catalytic activity and cellular binding.
    Werner F; Razzaq TM; Ellis V
    J Biol Chem; 1999 Jul; 274(31):21555-61. PubMed ID: 10419460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator.
    Klegerman ME; Zou Y; McPherson DD
    J Liposome Res; 2008; 18(2):95-112. PubMed ID: 18569446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4).
    Razzaq TM; Bass R; Vines DJ; Werner F; Whawell SA; Ellis V
    J Biol Chem; 2003 Oct; 278(43):42679-85. PubMed ID: 12913003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
    Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
    Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
    Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
    EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
    Jankun J; Skrzypczak-Jankun E
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
    Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M; Fredenburgh JC; Larsen GR
    J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion of the catalytic domain of tissue-type plasminogen activator by plasminogen activator inhibitor-1 coincides with the formation of stable serpin-proteinase complexes.
    Perron MJ; Blouse GE; Shore JD
    J Biol Chem; 2003 Nov; 278(48):48197-203. PubMed ID: 14500731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
    Bergum PW; Gardell SJ
    J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.
    Kim PY; Tieu LD; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2012 Feb; 287(7):4652-61. PubMed ID: 22187433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M; Sakata Y; Matsuda M; Mimuro J
    J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
    Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
    J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodination of the active site of tissue plasminogen activator: a method for radiolabeling serine proteases with tyrosylprolylarginyl chloromethyl ketone.
    Keyt BA; Berleau LT; Nguyen HV; Bennett WF
    Anal Biochem; 1992 Oct; 206(1):73-83. PubMed ID: 1456445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI
    J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of initiation of fibrinolysis by fibrin.
    Medved L; Nieuwenhuizen W
    Thromb Haemost; 2003 Mar; 89(3):409-19. PubMed ID: 12624622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.